Mentions in press and media 4
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Sep 18, 2026 | Robigo Announces Series A Funding | CAMBRIDGE, MA, Robigo, a biotechnology company engineering no-compromise biological solutions for crop protection, has announced a Series A funding. >> Click here for more funding data on Robigo >> To export Robigo funding data... |
| Sep 17, 2026 | Robigo Bio eyes commercialization for its ag biologicals with Leaps by Bayer investment | Robigo Bio has closed a Series A financing round to accelerate the commercial launch of its crop biological products, which the company claims can match or outperform synthetic chemistries instead of merely complementing them. Importantly, ... |
| May 16, 2022 | BREAKING: Vestaron banks $82m Series C funding for its crop-protecting peptides | US biotech startup Vestaron, which is devleoping biological alternatives to chemical-based crop controls using peptides, has raised $82 million in its Series C funding round. Private investment officer Ordway Selections and Cavallo Ventures... |
Reviews 0
FAQ about Endeavor8
What has the press written about Endeavor8?
Parsers VC has collected 4 articles mentioning Endeavor8, among them “Robigo Announces Series A Funding” (Sep 18, 2026) and “Robigo Bio eyes commercialization for its ag biologicals with Leaps by Bayer investment” (Sep 17, 2026).
Is Endeavor8 still active?
Yes, Endeavor8 is active; its latest activity on Parsers VC dates from Sep 18, 2026.